- Filed
- May 16, 2022 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2022 · Mar 31, 2022 | 30.29M sh |
| Long Term Debt | Q1 2022 · Mar 31, 2022 | $524.11K |
| Long Term Debt | Q1 2022 · Dec 31, 2021 | $541.75K |
| Short Term Debt | Q1 2022 · Mar 31, 2022 | $19.59M |
| Short Term Debt | Q1 2022 · Dec 31, 2021 | $18.84M |
| Cash And Equivalents | Q1 2022 · Mar 31, 2022 | $20.6M |
| Cash And Equivalents | Q1 2022 · Dec 31, 2021 | $18.23M |
| Stockholders Equity | Q1 2022 · Mar 31, 2022 | $39.63M |
| Stockholders Equity | Q1 2022 · Dec 31, 2021 | $38.75M |
| Current Liabilities | Q1 2022 · Mar 31, 2022 | $51.69M |
| Current Liabilities | Q1 2022 · Dec 31, 2021 | $53.84M |
| Total Liabilities | Q1 2022 · Mar 31, 2022 | $56.38M |
| Total Liabilities | Q1 2022 · Dec 31, 2021 | $58.61M |
| Current Assets | Q1 2022 · Mar 31, 2022 | $110.31M |
| Current Assets | Q1 2022 · Dec 31, 2021 | $110.5M |
| Total Assets | Q1 2022 · Mar 31, 2022 | $127.13M |
| Total Assets | Q1 2022 · Dec 31, 2021 | $127.78M |
| Cost Of Revenue | Q1 2022 · Mar 31, 2022 | $19.01M |
| Cost Of Revenue | Q1 2022 · Mar 31, 2021 | $18.97M |
| Shares Diluted | Q1 2022 · Mar 31, 2021 | 29.42M sh |
| Capex | Q1 2022 · Mar 31, 2021 | $57.52K |
| Operating Cash Flow | Q1 2022 · Mar 31, 2021 | $6.45M |
| Eps Diluted | Q1 2022 · Mar 31, 2021 | $0.08 |
| Eps Basic | Q1 2022 · Mar 31, 2021 | $0.08 |
| Sga Expense | Q1 2022 · Mar 31, 2021 | $6.09M |
| Net Income | Q1 2022 · Mar 31, 2021 | $2.41M |
| Operating Income | Q1 2022 · Mar 31, 2021 | $4.89M |
| Gross Profit | Q1 2022 · Mar 31, 2021 | $11.56M |
| Revenue | Q1 2022 · Mar 31, 2021 | $30.53M |